Fu Shang
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
Papers in
-
- Ubiquitin and proteasome pathways 32
- Connexins and lens biology 27
- Retinoids in leukemia and cellular processes 7
-
- Retinal Diseases and Treatments 18
- Co-authors
- Allen Taylor (51 shared papers)Xin Gong (9 shared papers)Thomas Nowell (9 shared papers)Paulo Pereira (12 shared papers)Graham S. Taylor (11 shared papers)Edward J. Dudek (9 shared papers)Martin S. Obin (4 shared papers)Jeffrey B. Blumberg (3 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (18 papers)Experimental Eye Research (9 papers)The FASEB Journal (8 papers)Current Molecular Medicine (6 papers)Free Radical Biology and Medicine (5 papers)
- Partner nations
- United StatesChinaPortugal
In The Last Decade
Fu Shang
96 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 120
- Clinical Biochemistry 548
- Ophthalmology 716
- Biochemistry 369
- Cell Biology 899
- Aging 86
Countries citing papers authored by Fu Shang
This map shows the geographic impact of Fu Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Shang more than expected).
Fields of papers citing papers by Fu Shang
This network shows the impact of papers produced by Fu Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Shang. The network helps show where Fu Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 341 | |
| 2 | 1997 | 234 | |
| 3 | 1997 | 203 | |
| 4 | 2012 | 195 | |
| 5 | 1998 | 174 | |
| 6 | 2011 | 156 | |
| 7 | 1995 | 139 | |
| 8 | 2011 | 135 | |
| 9 | 2003 | 122 | |
| 10 | 2010 | 110 | |
| 11 | 2001 | 101 | |
| 12 | 2004 | 98 | |
| 13 | 2006 | 96 | |
| 14 | 2006 | 94 | |
| 15 | Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells. | 2011 | 87 |
| 16 | 1999 | 82 | |
| 17 | 2008 | 80 | |
| 18 | 2001 | 79 | |
| 19 | 1997 | 77 | |
| 20 | 2005 | 77 |
About Fu Shang
Fu Shang is a scholar working on Molecular Biology, Ophthalmology, Clinical Biochemistry, Cell Biology and Epidemiology, having authored 97 papers that have together received 4.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (32 papers), Connexins and lens biology (27 papers), Advanced Glycation End Products research (21 papers), Retinal Diseases and Treatments (18 papers), Endoplasmic Reticulum Stress and Disease (14 papers), Toxoplasma gondii Research Studies (9 papers), Antioxidant Activity and Oxidative Stress (8 papers) and Retinoids in leukemia and cellular processes (7 papers). The work is most often cited by research in Clinical Biochemistry (548 citations), Ophthalmology (716 citations), Biochemistry (369 citations), Cell Biology (899 citations) and Aging (86 citations). Fu Shang has collaborated with scholars based in United States, China and Portugal. Frequent co-authors include Allen Taylor, Xin Gong, Thomas Nowell, Paulo Pereira, Graham S. Taylor, Edward J. Dudek, Martin S. Obin, Jeffrey B. Blumberg, Qingning Bian and Carla Marques. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Experimental Eye Research, The FASEB Journal, Current Molecular Medicine and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.